Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective
|
|
|
- Luke Harrell
- 5 years ago
- Views:
Transcription
1 第 53 回日本癌治療学会学術集会 ASCO, ESMO, ECCO からの招聘演者と講演予定 Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective Ralf A. Stahel (President of European Society of Medical Oncology, ESMO) Globalization of Precision Medicine in Oncology Mark J. Ratain (Personalized Therapeutics, University of Chicago, USA) Germline Genetic Analysis and Cancer Pharmacogenomics Jedd D. Wolchok (Memorial Sloan Kettering Cancer Center, USA) Cancer Immunotherapy with Combination Checkpoint Blockade
2 Jelle Barentsz (Radiology Researchers, UMC St Radboud, Netherlands) Molecular and Functional Imaging of Lymph Node Metastasis Stephen J. Chanock (NCI Cancer Genomics Research Laboratory, USA) Germline Genetic Analysis and Cancer Susceptibility J. Jack Lee (University of Texas MD Anderson Cancer Center, USA) Clinical Trial for Novel Cancer Therapy in Precision Medicine Era Christophe Le Tourneau (Institut Curie, France) Frontier of Precision Medicine in Oncology: Progress of SHEVA Trial
3 Teresa K. Woodruff (Obstet and Gynecology, Northwestern University, USA) Recent Advancement on Fertility Preservation of Young Cancer Patients: Globalization of Oncofertility Consortium Hamish Wallace (Royal Hospital for Sick Children, The University of Edinburgh, UK) Evaluation of Ovarian Tissue Cryopreservation and Transplantation based on Edinburgh Selection Criteria Jonathan A. Ledermann (University College London, UK) Personalization in Gynecologic Cancer Therapeutics: Future Perspective Elise C. Kohn (National Cancer Institute, USA) Molecular Profiling and Ovarian Cancer Treatment; Where are we Now?
4 Helen MacKay (Princess Margaret Hospital, University of Toronto, Canada) Intratumoral Genetic Heterogeneity of Ovarian Cancer Noralane M. Lindor (Laboratory Medicine and Pathology, Mayo Clinic, USA) Genetic Counseling and Management for Hereditary Cancer Risk in USA David E. Cohn (Obstetrics and Gynecology, The Ohio State University, USA) Prevention of Breast and Ovarian Cancer in HBOC Family Members Fortunato Ciardiello (President Elect of ESMO, Napoli, Italy) Toward Personalized Medicine in Oncology: Current and Future Perspective
5 Julie M. Vose (President Elect of ASCO, Nebraska Medical Center, USA) My Life and Academic Career Peter Naredi (President Elect of ECCO, University of Gothenburg, Sweden) Personalization of Surgery and Management for Hepatocellular Carcinoma David I. Quinn(USC Norris Comprehensive Cancer Center, Keck School of Medicine of USC) Precision Medicine in Multidisciplinary Therapy for Renal Cancer Arno J. Mundt (UC San Diego Moores Cancer Center, USA) Chemoradiotherapy for Locally Advanced Cervical Cancer: Where are we now?
6 Charles M. Rudin(Memorial Sloan Kettering Center, USA) Precision Medicine for Lung Cancer Therapy: Future Perspective Antonio Palumbo(Department of Oncology, University of Torino, Italy) Personalized Treatment for Multiple Myeloma Carol R. Bradford (Otolaryngology, Head and Neck Surgery, University of Michigan, USA) New Era on Surgery, Chemotherapy and Radiotherapy for Head and Neck Cancer Johann S. de Bono (Drug Development Unit / Prostate Cancer Team, Institute of Cancer Research, Royal Marsden Hospital, UK) Recent Advancement of Personalized Therapy for Prostate Cancer
7 James L. Abbruzzese(Medical Oncology, Duke Cancer Institute, USA) Recent Global Advances in Pancreas Cancer Therapeutics Michael J. Birrer(Massachusetts General Hospital, Harvard Medical School, USA) Future Direction of Ovarian Cancer Research and Clinical Trials David Chibula (Obstetrics and Gynecology, Charles University, Czech Republic) Personalization of Surgery for Endometrial Cancer John M. Maris (The Children's Hospital of Philadelphia, USA) Precision Medicine for Childhood Cancer Treatment
8 Julio Garcia-Aguila (Colorectal Surgery, Memorial Sloan Kettering Cancer Center, USA) Personalization of Surgery, Chemotherapy and Radiotherapy for Colorectal Cancer
Supplemental Table 1.1: Prostate cancer prognostic tools
Supplemental Table 1.1: Prostate cancer prognostic tools Features ANN^ BioChemical Capra^ CSQS EBRT Han Outcomes Cancer Specific - - +* + - - Non-Cancer Specific - - - + - - DFS/PFS +* +* +* - +* +* Clinical
SCOTTISH ONCOLOGY SUMMIT Double Tree by Hilton, Dunblane Hydro, Dunblane 1 st - 2 nd September 2017
Friday 1 st September 1300h 1400h Lunch (arrival, registration at conference foyer, coffee and sponsors exhibition) 1400h 1420h Prof Robert Jones Welcome/Announcements 1430h 1600h Parallel sessions: Lung
JOINT STATEMENT BY MEMBERS OF THE NATIONAL COMPREHENSIVE CANCER NETWORK PROSTATE CANCER GUIDELINES PANEL
JOINT STATEMENT BY MEMBERS OF THE NATIONAL COMPREHENSIVE CANCER NETWORK PROSTATE CANCER GUIDELINES PANEL We represent 23 of our nation s leading cancer hospitals on the National Comprehensive Cancer Network
Ludwig Presence at 2016 ASCO Annual Meeting
Ludwig Scientist(s) Affiliation(s) Session and Presentation Time Location Track Session Type/Title Presentation and/or Abstract Title Friday, June 3, 2016 Luisa Lina Villa Ludwig Sao Paulo 1:00pm - 3:15pm
Chapter 17 Oncofertility Consortium Consensus Statement: Guidelines for Ovarian Tissue Cryopreservation
Chapter 17 Oncofertility Consortium Consensus Statement: Guidelines for Ovarian Tissue Cryopreservation Leilah E. Backhus, MD, MS, Laxmi A. Kondapalli, MD, MS, R. Jeffrey Chang, MD, Christos Coutifaris,
ESMO Symposium on Immuno-Oncology Programme book
IMMUNO-ONCOLOGY SYMPOSIUM ESMO Symposium on Immuno-Oncology Programme book Advances in cancer immunotherapy; From vaccines to antibodies and cell therapies Geneva Switzerland 15-16 NOVEMBER 2013 esmo.org
St. Michael s Hospital, Department of Medical Imaging invites you to join us for a live conference and live webinar: 4 th Annual MRI Symposium
2017 St. Michael s Hospital, Department of Medical Imaging invites you to join us for a live conference and live webinar: 4 th Annual MRI Symposium September 16, 2017 MRI for Oncology Program This event
ALBERTA PRINCIPAL INVESTIGATORS
ALBERTA PRINCIPAL INVESTIGATORS Dr. Gregory Cairncross is Head of the Department of Clinical Neurosciences at the University of Calgary and holder of the Alberta Cancer Foundation Chair in Brain Tumor
Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd
Spanish National Cancer Research Centre CNIO Frontiers Meetings 2015 Madrid 22 25 March 2015 New Trends in Anticancer Drug Development Application deadline February 23 rd Organisers Manuel Hidalgo Alberto
FERTIPROTECT rd Annual Conference
Fertility Preservation in Cancer Patients FERTIPROTECT 2016 3 rd Annual Conference Fertility Preservation Society (India) 27 th & 28 th August, 2016 Hotel Lalit Ashok, Bengaluru, India Fertility Preservation
Gastric Cancer Co-Chairs Speakers LEARNING OBJECTIVES
ESMO Preceptorship Programme Gastric Cancer Multidisciplinary management, standards of care, therapeutic targets and future perspectives 10-11 June 2016, Prague, Czech Republic Co-Chairs Andres Cervantes
Oncofertility: The Preservation of Fertility Options for Young People with Cancer
Oncofertility: The Preservation of Fertility Options for Young People with Cancer Teresa K. Woodruff, Ph.D. The Thomas J. Watkins Professor of Obstetrics and Gynecology Northwestern University Feinberg
Background Management of high risk, early stage endometrial cancer is controversial. Historically, adjuvant pelvic radiation therapy is standard for
A Phase III Trial of Pelvic Radiation Therapy versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-risk, Early-stage Endometrial Cancer: A Gynecology
Multigene Panel Testing for Hereditary Cancer Risk
Multigene Panel Testing for Hereditary Cancer Risk Dana Zakalik, M.D. Director, Nancy and James Grosfeld Cancer Genetics Center Professor, OUWB Medical School MCC Annual Meeting November 4, 2015 Outline
Steamboat Springs, Colorado. January 15-18, 2016
Friday, January 15, 2016 Registration: Begins at 2:00 pm Plenary Session: 4:00 pm - 6:00 pm 14 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 15-18, 2016 Current Status
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme 14-19 July 2016, Valencia, Spain Co-chairs: Andrés Cervantes, ES - Nicholas Pavlidis, GR - Susana Banerjee, UK Thursday, 14
Hall 406. Title: Opening & Keynote. Hall 405. Title: Treatment of node positive bladder. Hall 404
23-11-2018 10:00-11:30 Type: Opening session Title: Opening & Keynote Hall 406 11:45-12:30 Type: Challenge Your Expert session Title: Treatment of node positive bladder 11:45-11:55 Treatment of node positive
ENYGO REPORT. Summary
ENYGO REPORT Summary The first ENYGO Workshop on Fertility Sparing in Gynaecological Oncology was held at La Paz University Hospital in Madrid (Spain) from 27 to 28 January 2017. It was a very successful
PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019
MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments
Ovarian Cancers: Evolving Paradigms in Research and Care Report Release Wednesday, March 2, 2016
Ovarian Cancers: Evolving Paradigms in Research and Care Report Release Wednesday, March 2, 2016 Committee Membership Jerome F. Strauss, III, (Chair), Virginia Commonwealth University School of Medicine
第 1 章医学英語. 1. 病院 Hospital 人体 Human Body 20. Preface. English of Medical Terms
目次 Contents Preface 第 1 章医学英語 English of Medical Terms 1. 病院 Hospital 12 1 nurses Ns 12 2 doctors Drs 13 3 other hospital staffs 14 4 parts of hospital 15 5 others 18 2. 人体 Human Body 20 1 external body
CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018
CDx in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900 Research unit Versailles Saint-Quentin-en-Yvelines
Clinical utility of precision medicine in oncology
Clinical utility of precision medicine in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900
Qualification Statement: As Assistant Professor and Director of Clinical & Community Relations, Professor Longpré is part of the founding faculty for
Qualification Statement: As Assistant Professor and Director of Clinical & Community Relations, Professor Longpré is part of the founding faculty for the Entry-Level Doctor of Occupational Therapy in Tampa.
2008 Oncology Pharmacy Preparatory Review Course Learning Objectives
2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,
DEPARTMENT OF ONCOLOGY ELECTIVE
DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:
Precision Genetic Testing in Cancer Treatment and Prognosis
Precision Genetic Testing in Cancer Treatment and Prognosis Deborah Cragun, PhD, MS, CGC Genetic Counseling Graduate Program Director University of South Florida Case #1 Diana is a 47 year old cancer patient
International Symposium on FERTILITY PRESERVATION Basic Research to Clinical Applications
International Symposium on FERTILITY PRESERVATION Basic Research to Clinical Applications 28 th February and 1 st March 2015 Kasturba Medical College, Manipal-576104, India First Announcement Invitation
Unknown Primary Service for patients at Chesterfield Royal Hospital
Unknown Primary Service for patients at Chesterfield Royal Hospital David Brooks Macmillan Consultant in Palliative Medicine Louise Merriman GP Cancer Lead With thanks to Macmillan Cancer Support, who
AGENDA: FEBRUARY 22, 2018 INTRODUCTION
FDA-AACR-ASTRO Clinical Development of Drug-Radiotherapy Combinations Workshop with support from Cancer Research UK Combinations Alliance February 22-23, 2018 Bethesda, MD Purpose: There is great interest
Charisse Litchman Editor. Desmoid Tumors
Desmoid Tumors Charisse Litchman Editor Desmoid Tumors 1 3 Editor Dr. Charisse Litchman Department of Neurology, The Stamford Hospital, Stamford, CT 06904 Assistant Clinical Professor, Department of Neurology,
SLN Mapping in Cervical Cancer. Memorial Sloan Kettering Cancer Center New York, USA
Lead Grou p Log SLN Mapping in Cervical Cancer Nadeem R. Abu-Rustum, M.D. Memorial Sloan Kettering Cancer Center New York, USA Conflict of Interest Disclosure Nadeem R. Abu-Rustum, M.D. I have no financial
Adaptive Design of Affordable Clinical Trials Using Master Protocols in the Era of Precision Medicine
Adaptive Design of Affordable Clinical Trials Using Master Protocols in the Era of Precision Medicine Tze Leung Lai Dept. of Statistics, Biomedical Data Science, Computational & Mathematical Engineering;
Macmillan Publications
S1 S2 S3 S3 S3 S4 S5 S6 S7 S8 S8 S9 S10 S11 S11 S12 S13 S14 S15 S17 S18 S19 Bladder Cancer: Non-Invasive, Invasive and Advanced Bone Cancer: Primary, Secondary Colon Cancer, Anal Cancer, Rectal Cancer
Future Therapeutic Developments in Head and Neck Cancer
Future Therapeutic Developments in Head and Neck Cancer Professor Kevin Harrington Joint Head of Division of Radiotherapy and Imaging The Institute of Cancer Research/The Royal Marsden NIHR Biomedical
Discussing Fertility Preservation with Breast Cancer Patients
Chapter 35 Discussing Fertility Preservation with Breast Cancer Patients Jacqueline S. Jeruss J.S. Jeruss (B) Department of Surgery, Robert H. Lurie Comprehensive Cancer Center, Northwestern University
第 108 回日本精神神経学会学術総会 教育講演 REM REM 索引用語 はじめに. sleep psychiatry 26
782 2013 115 7 第 108 回日本精神神経学会学術総会 教育講演 4 5 1 5 8,000 1 REM 2005 8 REM 索引用語 はじめに sleep psychiatry 26 108 2012 5 24 26 783 Ⅰ. 睡眠医学の研究の歴史 4 5 1 3 5 8,000 14 1 38 1929 Berger, H. von Economo 1953 Kleitman,
SENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER
SENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER Clinical Practice Guideline Update Introduction The original ASCO evidence-based clinical practice guidelines on use of sentinel node
MEDICAL ONCOLOGY ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN. 27 June - 2 July 2014 Brdo, Slovenia. Chairs: T. Cufer, SI R.
Flyer MMO_(4 Mar)_screen 04.04.2014 09:33 Pagina 3 MASTERCLASS ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN MEDICAL ONCOLOGY 27 June - 2 July 2014 Brdo, Slovenia Chairs: R. Herrmann, CH This
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer. American Society of Clinical Oncology Clinical Practice Guideline
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer American Society of Clinical Oncology Clinical Practice Guideline Introduction ASCO convened an Expert Panel to develop recommendations
Dr. Sause: Clinical, Research, and Administration. Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah
Dr. Sause: Clinical, Research, and Administration Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah Objectives: Identify Dr. Sause's educational achievements Discuss
ECC or Margins Positive?
CLINICAL PRESENTATION This practice algorithm has been specifically developed for M. D. Anderson using a multidisciplinary approach and taking into consideration circumstances particular to M. D. Anderson,
Auditorium. Title: Welcome and Introduction by the Chairs Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES
08-04-2017 12:45-13:00 Type: Educational session Title: Welcome and Introduction by the Chairs 1 2 1 2 Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES 12:45-13:00 Welcome 13:00-13:15
BGCS Thursday 5 th July. Time Session Location 7:30-9:20 Registration. 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford
Thursday 5 th July Time Session Location 7:30-9:20 Registration 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford 8:00-9:00 INDUSTRY SPONSORED MEETING Wesley 9:20-9:30 Welcome and introduction Mr Tim Mould
Oncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
THE UC SANTA CRUZ GENOMICS INSTITUTE. David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director
THE UC SANTA CRUZ GENOMICS INSTITUTE David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director April 8, 2015 OUR MISSION Unlocking the world s genomic data to accelerate medical
Scientific Program, 2 nd ISFP World Congress
Thursday, December 8, 2011, Fontainebleau Hotel, Miami Beach, FL 07:30 19:00: Registration (North Lobby) 06:30 07:30: Continental Breakfast (Shimmer) HANDS-ON WORKSHOP for FERTILITY PRESERVATION (Flash)
56 th Annual Meeting American Society for Radiation Oncology. Advances in Lung Caner News Briefing
56 th Annual Meeting American Society for Radiation Oncology Advances in Lung Caner News Briefing Moderator: Benjamin Movsas, MD, FASTRO Tuesday, Sept. 16, 2014 7 a.m. (PT) Long-term Results of RTOG 0236:
Ontario s Initiatives in Surgical Quality- The Successes & Where We are Going
Ontario s Initiatives in Surgical Quality- The Successes & Where We are Going Robin S. McLeod Professor of Surgery and Health Policy, Management and Evaluation University of Toronto Lead, Quality Improvement
Dr Graeme Suthers: The genetic basis of cancer
Dr Graeme Suthers: The genetic basis of cancer Dr Suthers is the head of the Familial Cancer Unit at the Women s and Children s hospital. He will begin the evening with an introduction to cancer and its
American Cancer Society, Inc. Extramural Grants
Page: 1 Graduate Scholarships in Cancer Nursing Practice (GSCNP) GSCNP-17-124-01 Ranney, Lori, MSN MENTOR: Foote, Jane, EdD, MSN, RN Winona State University MN Graduate Scholarship in Cancer Nursing Practice
CYPRESS U CRITICAL UPDATE
CYPRESS U CRITICAL UPDATE CASE STUDIES IN CANCER CARE MANAGEMENT John Van Dyke, Interlink Copyright INTERLINK Care Management, Inc. 2014 Presented by: John Van Dyke Chief Executive Officer INTERLINK COE
DONNA BOWERS & ALAN MILLER
BAYLOR HEALTH CARE SYSTEM ONCOLOGY NETWORK NEWS UPDATE WITH YOUR BHCS ONCOLOGY ANCHORS DONNA BOWERS & ALAN MILLER 1 The Evolution of Cancer Care Slash, burn and poison era Precision Medicine Casting out
Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
ESO-ASCO MASTERCLASS IN CLINICAL ONCOLOGY November 2018 Yerevan, Armenia MASTERCLASS
ESO-ASCO MASTERCLASS IN CLINICAL ONCOLOGY 10-13 November 2018 Yerevan, Armenia Chairs: G. Curigliano, IT F. Peccatori, IT Host Chair: G. Tamamyan, AM Held in collaboration with MASTERCLASS AIMS AND OBJECTIVES
Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves Douillard, France
ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Prague, Czech Republic 6-7 July 2016 CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves
American Cancer Society, Inc. Extramural Grants
Page: 1 Cancer Control Career Development Award for Primary Care Physicians (CCCDA) CCCDA-14-013-01 Cole, Allison M., MD MENTOR: Baldwin, Laura-Mae, MD, MPH Department of Family Medicine Improving Colorectal
Year Book 7 副腎 国立成育医療研究センター研究所 分子内分泌研究部 勝又規行 第 51 回日本内分泌学会学術総会
Year Book 7 副腎 国立成育医療研究センター研究所 分子内分泌研究部 勝又規行 第 51 回日本内分泌学会学術総会 日本小児内分泌学会 CO I 開示 筆頭発表者名 : 勝又規行 日本小児内分泌学会の定める利益相反に関する開示事項はありません 方法 2016 年 9 月 1 日から2017 年 8 月 31 日まで 英文論文をPubMedで検索 Key Words Adrenal insufficiency
COSA Invited International Speakers
bs_bs_banner COSA Invited International Speakers 9 COSA Invited International Speakers Thomas Aloia University of Texas M.D. Anderson Cancer Center, Texas, USA Associate Professor, Surgical Oncology, The
NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016
33rd Annual Meeting NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016 Thursday-Friday, June 16-17, 2016 Conference Location: MEMORIAL SLOAN KETTERING CANCER CENTER Rockefeller Research
Preliminary programme ESLCCC September 2016
Preliminary programme ESLCCC 2016 22-23 September 2016 1 st day - Thursday 22 September 2016 8.45 17.00 Registration starts at 7.30 in the morning Welcome and Introduction By the ESLCCC 16 Committee Female
Cancer immunotherapy with oncolytic viruses: more than just lysis
Cancer immunotherapy with oncolytic viruses: more than just lysis Dmitriy Zamarin MD PhD Assistant Attending, Immune Therapeutics Center Memorial Sloan-Kettering Cancer Center New York, NY BCAN Think Tank
Page 1 of 8 TABLE OF CONTENTS
Page 1 of 8 TABLE OF CONTENTS Patient Evaluation and Recommendation..Page 2 Testing and Follow-up..Page 3 Genetic Counseling Referral Criteria.....Page 4-5 Patient Education..Page 6 Suggested Readings...Page
DCIS: Margins and the USC/VNPI
DCIS: Margins and the USC/VNPI Van Nuys USC Hoag Melvin J. Silverstein, M.D Gross Endowed Chair in Oncoplastic Surgery Director, Hoag Breast Program Newport Beach, CA Clinical Professor of Surgery Keck
55 th Annual Meeting American Society for Radiation Oncology. Patients: Hope Guide Heal News Briefing
55 th Annual Meeting American Society for Radiation Oncology Patients: Hope Guide Heal News Briefing Sunday, September 22, 2013 4:45 p.m. 5:15 p.m. Colleen A.F. Lawton, MD, FASTRO 2013 ASTRO President
Presented at the 59th American Society of Hematology (ASH) Annual Meeting & Exposition; December 9 12, 2017; Atlanta, GA, USA
65 Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma From the Phase 2 CheckMate 25 Study Jonathon B. Cohen, 1 Andreas
Trends in Cancer Survival in NSW 1980 to 1996
Trends in Cancer Survival in NSW 19 to 1996 Xue Q Yu Dianne O Connell Bruce Armstrong Robert Gibberd Cancer Epidemiology Research Unit Cancer Research and Registers Division The Cancer Council NSW August
Professional International Study Management
Professional International Study Management Services Phase I Study Consulting Phase II-IV IV Study Conduct for Drugs and Devices Protocol Design and Development Study Feasibilities Site Identification,
M. Patrick Lowe, M.D. Curriculum Vitae
M. Patrick Lowe, M.D. Curriculum Vitae EDUCATION University of Southern California Keck School of Medicine Women and Children`s Hospital Department of Obstetrics and Gynecology Division of Gynecologic
Stage IB1 (2-4 cm) Cervical cancer treated with Neoadjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA) Dre Marie Plante
Stage IB1 (2-4 cm) Cervical cancer treated with Neoadjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA) Dre Marie Plante Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical
Annals of Oncology Advance Access published July 10, 2014
Annals of Oncology Advance Access published July 10, 2014 1 Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals Oncology Jan;25(1):
BGCS Thursday 5 th July. Time Session Location 7:30-9:20 Registration. 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford
Thursday 5 th July Time Session Location 7:30-9:20 Registration 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford 8:00-9:00 INDUSTRY SPONSORED MEETING Wesley 9:20-9:30 Welcome and introduction Mr Tim Mould
News from ASCO. Niven Mehra, Medical Oncologist. Radboud UMC Institute of Cancer Research and The Royal Marsden Hospital
News from ASCO Niven Mehra, Medical Oncologist Radboud UMC Institute of Cancer Research and The Royal Marsden Hospital Disclosures Speaker fees: Merck, Bayer Advisory boards: Janssen-Cilag Research and
How can we reduce the mortality from melanoma in Australia?
How can we reduce the mortality from melanoma in Australia? Professor Grant McArthur MB BS PhD Peter MacCallum Cancer Centre Melbourne, Australia University of Melbourne, Parkville, Australia What is melanoma?
BRCA2 gene. Associated Syndrome Name: Hereditary Breast and Ovarian Cancer syndrome (HBOC) BRCA2 Summary Cancer Risk Table. BRCA2 gene Overview
BRCA gene Associated Syndrome Name: Hereditary Breast and Cancer syndrome (HBOC) BRCA Summary Cancer Risk Table Male Breast GENETIC RISK Female Breast Elevated Risk Elevated Risk BRCA gene Overview Hereditary
Session Chair: Lynette Denny, University of Cape Town, Cape Town, South Africa
WEDNESDAY, JANUARY 18 Concurrent Sessions 1-2 15:00-16:30 Cervical Cancer Ballroom East Session Chair: Lynette Denny, University of Cape Town, Cape Town, South Africa Progress in scaling up cervical cancer
2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives
2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives Acute Leukemia/Tumor Lysis Syndrome John M. Valgus, Pharm.D., BCOP Hematology/Oncology Specialist University of North
UCL CANCER INSTITUTE. The UCLH / UCL Cancer Clinical Research Facility
UCL CANCER INSTITUTE The UCLH / UCL Cancer Clinical Research Facility The UCLH / UCL Cancer Clinical Research Facility (CCRF) The CCRF is a state-of-the-art facility for cancer drug development. Located
MEDICAL POLICY. SUBJECT: MOLECULAR PANEL TESTING OF CANCERS TO IDENTIFY TARGETED THERAPIES (Excluding NSCLC and CRC) EFFECTIVE DATE: 12/21/17
MEDICAL POLICY SUBJECT: MOLECULAR PANEL TESTING OF PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
References 1. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, CA Cancer J Clin, (1): p Keegan, T.H., et al., Compa
1. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2018. CA Cancer J Clin, 2018. 68(1): p. 7 30. 2. Keegan, T.H., et al., Comparison of cancer survival trends in the United States of adolescents
ORGANISING COMMITTEE
ORGANISING COMMITTEE Dr Anthony Maxwell (Chair) Dr Sarah Vinnicombe (Vice Chair) Dr Sheetal Sharma (Meetings Secretary) Dr Nisha Sharma (Secretary) Dr Julie Cox (Treasurer) Professor Iain Lyburn (Research)
Acupuncture Needles. Overview. Gary Deng, MD,PhD. Traditional Theories. Acupuncture in Cancer Care: the USA Experience. History. Research Activities
, MD,PhD Acupuncture in Cancer Care: the USA Experience History Overview First ISS-ARTOI Conference on Integrative Oncology Fifth ARTOI International Congress Rome, Italy Nov 7, 2013, MD, PhD Integrative
8:30-9:00 Increased dependence on glutamine in PTEN-deficient breast cancer Ramon E. Parsons, Icahn School of Medicine at Mount Sinai, New York, NY
CONFERENCE PROGRAM SATURDAY, OCTOBER 7 3:00 p.m.-7:00 p.m. Salon 3 of the Terrace Welcome and Keynote Lectures 6:00 p.m.-7:30 p.m. Session Chair: Ramon E. Parsons, Icahn School of Medicine at Mount Sinai,
Pediatric Otolaryngology Fellowship News & Events
Pediatric Otolaryngology Fellowship News & Events Holinger Symposium October 18, 2014 The educational symposium featured presentations from physicians who were trained by Dr. Lauren D. Holinger and who
Cancer Researchers Report Longer Survival Rates With Immunotherapy
http://nyti.ms/1jlz74z HEALTH NYT NOW Cancer Researchers Report Longer Survival Rates With Immunotherapy By ANDREW POLLACK JUNE 2, 2014 CHICAGO Drugs that unleash the body s immune system to combat tumors
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS Madrid, 9 th -11 th May, 2018 PRELIMINARY PROGRAM Meeting Directors: Registrations: www.mdanderson.es/embracingnewstandards
2015 EUROPEAN CANCER CONGRESS
2015 EUROPEAN CANCER CONGRESS 25-29 September 2015 Vienna, Austria SUMMARY The European Cancer Congress (ECC 2015) combined the 40th European Society for Medical Oncology (ESMO) congress with the 18th
Roche Investor Relations ASCO Planner 2017
Roche Investor Relations ASCO Planner 2017 Saturday, June 3 Session Title: Lung Cancer Non-Small Cell Metastatic Date: Sat, June 3 Time: 8:00 AM 11:30 AM Speaker Name: Ibiayi Dagogo-Jack, MD; Yuichi Takiguchi,
Lynch Syndrome: A Public Health Approach
Lynch Syndrome: A Public Health Approach April 21, 2015 Sponsored by Genetic Alliance and APHA Genomics Forum Debra Duquette, MS, CGC Michigan Department of Health and Human Services (MDHHS) Genomics Coordinator
Cancer Prevention & Control in Adolescent & Young Adult Survivors
+ Cancer Prevention & Control in Adolescent & Young Adult Survivors NCPF Workshop July 15-16, 2013 Patricia A. Ganz, MD UCLA Schools of Medicine & Public Health Jonsson Comprehensive Cancer Center + Overview
Palliative care - the opportunities. Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital
Palliative care - the opportunities Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital Our Commitment to you for end of life care The Government Response to the
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,
Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain
CNIO Frontiers Meetings Primary and Secondary Brain Tumors 19th-22nd February 2017 Organisers: Richard Gilbertson CRUK Cambridge Institute, UK Michael Weller University Hospital Zurich, Switzerland Massimo
Chapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February
Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan
Introduction to Oncology and Chemotherapy October 23-24, 2013 San Francisco, CA
1 PROGRAM OUTLINE: Introduction to Oncology and Chemotherapy October 23-24, 2013 San Francisco, CA www.healthtech.com/ioc Description: Delegates attending this course will benefit from an introductory
9th Annual Global Implantology Week At NYU
9th Annual Global Implantology Week At NYU March 19-22, 2018 New York City, NY 1.5 Days Auxiliary Training 4.5 Days Clinical Topics 9 Speakers 21 CE Credits 2,200+ Attendees Since 2009 Build the framework